Newsletter | September 7, 2011

9.7.11 -- A New Paradigm For Strategic Partnerships

Clinical Leader
A New Paradigm For Strategic Partnerships
By Rob Wright, Clinical Leader

In an unprecedented move, John Hubbard, Ph.D., senior VP and worldwide head of development operations for Pfizer, announced the strategic partnering with two CROs, ICON and Parexel, as preferred clinical trial outsourcing providers. Hubbard sat down with me to discuss how the two-partner model evolved and how it is going to help spur innovation at the pharma giant.
Read more.

Featured Articles

Clinical Trials In Russia
The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor) and the Ministry of Health and Social Development of the Russian Federation (MoH) approved 492 new clinical trials of all types including local and bioequivalence studies during 2010, demonstrating a 15% decrease from the prior year's figure. Read more.

The Art Of Compliance Turning Compliance Into A Sustainable Business Advantage
The last few years have presented extraordinary regulatory and quality compliance challenges for pharmaceutical, biotechnology, and medical device companies charged to do more with less as a result of consolidation, restructuring, and economic uncertainty. Read more.

Excellence In Biomarkers
Biomarkers of disease are assuming an ever increasing role in the discovery and development of drugs. ICON has long recognized their importance in all phases of the development process and has built significant expertise in biomarker development and analysis. Read more.

Featured Products

Wallet Package Technology
The wallet package is an effective marketing tool and a growing number of pharmaceutical companies are following the trend towards packaging their blister cards in wallet packs. Read more.

Xcellerate Clinical Trial Optimization
Xcellerate helps ensure more cost-effective and timely clinical trials. Providing cutting edge site and investigator selection tools, clinical trial scenario planning, forecasting and resource management, Xcellerate can help you achieve a better return on your clinical investment. Read more.

Top News
Industry Event

2nd Quality Oversight Of Clinical Vendors Conference
October 17 to 19, 2011
Arlington, VA

The 2nd Quality Oversight of Clinical Vendors Conference aims to provide practical and applicable takeaways on topics such as key quality indicators, clinical monitoring, quality management plans, international oversight, and much more.


LinkedIn
LinkedIn